MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

trading halt, page-27

  1. 5,270 Posts.
    lightbulb Created with Sketch. 244
    Early or not, get ready: "the Company expects to make an announcement in relation to the results of its Phase 2B OPTIONS Study on obesity Drug AOD9604."

    The fact that the results are to be released this early means to me that the results are likely to be clear, unambiguous, and positive. Otherwise there would neither be the opprotunity nor the motivation for such an early release of results.

    I'm not booking any cruises just yet, but I continue to expect great things.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.